Literature DB >> 28696150

Curative-intent radical en bloc resection using a minimum of a 3 cm margin in feline injection-site sarcomas: a retrospective analysis of 131 cases.

Nina Müller1, Martin Kessler1.   

Abstract

Objectives Owing to its highly infiltrative growth, feline injection-site sarcoma (FISS) carries a significant risk of local tumour recurrence. Parameters of possible prognostic significance (eg, tumour size and location, resection of de novo vs recurrent tumours, and achievement of tumour-free surgical margins) were examined with regard to their influence on recurrence rate (RR), disease-free interval (DFI) and survival time (ST). Methods This was a retrospective analysis of cats with FISSs located on the chest or abdominal wall or the interscapular region treated in a single institution using a standardised radical resection technique with 3 cm lateral margins and full-thickness body wall resection (tumours over chest/abdominal wall) or a minimum of two fascial planes (interscapular tumours). Results Median postoperative DFI and ST of 131 cats with FISSs was 21 and 24 months, respectively. Patients operated on for recurrent tumours were significantly more likely to die from tumour-related reasons compared with patients with de novo tumours ( P <0.001). RR and DFI in the different tumour locations were comparable ( P = 0.544 and P = 0.17, respectively). Local tumour recurrence occurred in 38.1% of the cats. Cats operated on for tumour recurrences had a significantly higher chance of another recurrence (RR 55.5% vs 33.3%; P = 0.005). Completeness of excision was determined by taking tumour bed biopsies. Tumour bed biopsies that did not contain tumour cells were associated with a significantly lower RR compared with those with tumour cells (30.5% vs 76.2%). Conclusions and relevance Depending on prognostic factors such as surgery for primary vs recurrent tumour, tumour-free resection margins and tumour location, the RR in FISS ranges from 33-55%, despite curative intent radical surgery. This study may help in identifying patients at risk for recurrence.

Entities:  

Mesh:

Year:  2017        PMID: 28696150     DOI: 10.1177/1098612X17717882

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection-site sarcoma.

Authors:  Mary J Coleman; Laura E Selmic; Jonathan P Samuelson; Ryan Jennings; Pin-Chieh Huang; Eric M McLaughlin; Vincent A Wavreille; Josephine A Dornbusch; Janis Lapsley; James Howard; Edward Cheng; Alex Kalamaras; Kendra Hearon; Megan Cray; Janet Grimes; Brandan Wustefeld-Janssens; Katie Kennedy; Owen Skinner; Pierre Amsellem; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2021-09-14       Impact factor: 2.613

2.  Ventilatory failure in a cat following radical chest wall resection for feline injection site sarcoma.

Authors:  Samantha J Bilko; Stan Veytsman; Pierre M Amsellem; Rosalind S Chow
Journal:  JFMS Open Rep       Date:  2021-07-15

3.  Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.

Authors:  Filippo Torrigiani; Giorgio Romanelli; Paola Roccabianca; Elisabetta Treggiari
Journal:  JFMS Open Rep       Date:  2019-07-01

4.  Role of nuclear factor-kappa B in feline injection site sarcoma.

Authors:  Cheng-Shun Hsueh; Ching-Ho Wu; Cheng-Hsin Shih; Jason Lih-Seng Yeh; Chian-Ren Jeng; Victor Fei Pang; Hue-Ying Chiou; Hui-Wen Chang
Journal:  BMC Vet Res       Date:  2019-10-25       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.